Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC Joins Device Groups In Urging Quick Fix For Charge Compression

This article was originally published in The Gray Sheet

Executive Summary

The Medicare Payment Advisory Commission agrees with device stakeholders that CMS should act immediately to correct payment calculations that undervalue high-cost medical technologies

You may also be interested in...



Medicare In Brief

Neurostimulator payments: Medicare reimbursement for outpatient procedures to implant neurostimulator leads would increase 44% under the agency's proposed 2010 Outpatient Prospective Payment System (OPPS) rule, released July 1. The proposed boost follows a double-digit decrease in payment for the same procedure in 2009, which occurred despite protests from Cyberonics, maker of the Vagus Nerve Stimulation System for controlling epileptic seizures (1"The Gray Sheet" Sept. 1, 2008). CMS says the fluctuations in median costs for implantation of neurostimulator electrodes for the cranial nerve and for insertion of left ventricular pacing electrodes "are a consequence of the small number of single bills upon which the median costs are based and the small number of providers of these services." The agency also plans to consolidate the current three APC codes for neurostimulator generator implantation into two. Comments on the OPPS proposal are due Aug. 31; a final rule is expected by Nov. 1

Medicare In Brief

Neurostimulator payments: Medicare reimbursement for outpatient procedures to implant neurostimulator leads would increase 44% under the agency's proposed 2010 Outpatient Prospective Payment System (OPPS) rule, released July 1. The proposed boost follows a double-digit decrease in payment for the same procedure in 2009, which occurred despite protests from Cyberonics, maker of the Vagus Nerve Stimulation System for controlling epileptic seizures (1"The Gray Sheet" Sept. 1, 2008). CMS says the fluctuations in median costs for implantation of neurostimulator electrodes for the cranial nerve and for insertion of left ventricular pacing electrodes "are a consequence of the small number of single bills upon which the median costs are based and the small number of providers of these services." The agency also plans to consolidate the current three APC codes for neurostimulator generator implantation into two. Comments on the OPPS proposal are due Aug. 31; a final rule is expected by Nov. 1

CMS Releases New RTI And RAND Reports On Hospital Payment Calculations

CMS released two reports April 22 on alternative calculation methods that could affect hospital payments for device-intensive procedures in particular

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026252

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel